☰

Sonia Cellot, Ph.D. - Publications

Affiliations: 
2012 Molecular Biology Université de Montréal, Montréal, Canada 
Area:
Molecular Biology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

43 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Beaufils C, Proulx C, Blincoe A, Teira P, Bittencourt H, Cellot S, Duval M, Morin MP, De Bruycker JJ, Couture J, Samaan K, Decaluwe H, Kleiber N, El-Jalbout R, Touzot F, et al. Case report: Success of allogeneic hematopoietic stem cell transplantation for refractory systemic-onset juvenile idiopathic arthritis. Frontiers in Medicine. 10: 1275927. PMID 37908851 DOI: 10.3389/fmed.2023.1275927  0.389
2023 Gress V, Roussy M, Boulianne L, Bilodeau M, Cardin S, El-Hachem N, Lisi V, Khakipoor B, Rouette A, Farah A, Théret L, Aubert L, Fatima F, Audemard E, Thibault P, ... ... Cellot S, et al. CBFA2T3::GLIS2 Pediatric Acute Megakaryoblastic Leukemia is Sensitive to BCL-XL Inhibition by Navitoclax and DT2216. Blood Advances. PMID 37729615 DOI: 10.1182/bloodadvances.2022008899  0.612
2020 Milan T, Celton M, Lagacé K, Roques É, Safa-Tahar-Henni S, Bresson E, Bergeron A, Hebert J, Meshinchi S, Cellot S, Barabé F, Wilhelm BT. Epigenetic changes in human model KMT2A leukemias highlight early events during leukemogenesis. Haematologica. PMID 33375773 DOI: 10.3324/haematol.2020.271619  0.319
2019 Cardin S, Bilodeau M, Roussy M, Aubert L, Milan T, Jouan L, Rouette A, Laramée L, Gendron P, Duchaine J, Decaluwe H, Spinella JF, Mourad S, Couture F, Sinnett D, ... ... Cellot S, et al. Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities. Blood Advances. 3: 3307-3321. PMID 31698461 DOI: 10.1182/Bloodadvances.2019030981  0.451
2019 Pincez T, Landry JR, Roussy M, Jouan L, Bilodeau M, Laramée L, Couture F, Sinnett D, Gendron P, Hébert J, Oligny L, Rouette A, Tran TH, Wilhelm BT, Bittencourt H, ... Cellot S, et al. Cryptic recurrent ACIN1-NUTM1 fusions in non KMT2A-rearranged infant acute lymphoblastic leukemia. Genes, Chromosomes & Cancer. PMID 31515871 DOI: 10.1002/Gcc.22808  0.32
2019 Mourad S, Bilodeau M, Roussy M, Laramée L, Boulianne L, Rouette A, Jouan L, Gendron P, Duval M, Teira P, Hébert J, Bittencourt H, Pastore Y, Landry JR, Cellot S. as a Cooperating Mutation in AML Arising in the Context of Shwachman-Diamond Syndrome. Frontiers in Oncology. 9: 772. PMID 31475115 DOI: 10.3389/Fonc.2019.00772  0.347
2019 Milan T, Canaj HV, Villeneuve C, Ghosh A, Barabé F, Cellot S, Wilhelm BT. Pediatric Leukemia: moving towards more accurate models. Experimental Hematology. PMID 31154068 DOI: 10.1016/J.Exphem.2019.05.003  0.363
2019 Pincez T, Santiago R, Bittencourt H, Louis I, Teira P, Richer J, Cellot S, Duval M. Intensive minimal residual disease monitoring to drive early intervention after allogeneic hematopoietic stem cell transplant for pediatric acute leukemia. Journal of Clinical Oncology. 37: e18531-e18531. DOI: 10.1200/Jco.2019.37.15_Suppl.E18531  0.378
2019 Dakhallah N, Beauchemin M, Richer J, Cellot S, Teira P, Duval M, Bittencourt H. Impact of Modifying Conditioning and Immunosuppressive Strategies in Allogeneic Hematopoietic Stem Cell Transplantation in Children with Acute Lymphoblastic Leukemia Blood. 134: 5714-5714. DOI: 10.1182/Blood-2019-122988  0.426
2019 Mallette FA, Sawchyn C, Couteau F, Lalonde M, Boulay K, Glatz D, Fernandez-Diaz E, Zuber J, Cellot S, Mercier F. 3168 – INVESTIGATING THE ROLE OF THE KDM4A LYSINE DEMETHYLASE IN PEDIATRIC ACUTE MYELOID LEUKEMIA Experimental Hematology. 76: e2-e3. DOI: 10.1016/J.Exphem.2019.09.010  0.453
2019 Wilhelm B, Milan T, Celton M, Lagacé K, Roques E, Bresson E, Bergeron A, Hebert J, Lamontagne V, Cellot S, Barabé F. THE INTEGRATED USE OF HUMAN MODELS OF LEUKEMIA TO IDENTIFY POTENTIAL THERAPEUTIC TARGETS Experimental Hematology. 76: S92-S93. DOI: 10.1016/J.Exphem.2019.06.460  0.45
2018 Benadiba J, Ansari M, Krajinovic M, Vachon MF, Duval M, Teira P, Cellot S, Bittencourt H. Pharmacokinetics-adapted Busulfan-based myeloablative conditioning before unrelated umbilical cord blood transplantation for myeloid malignancies in children. Plos One. 13: e0193862. PMID 29608607 DOI: 10.1371/Journal.Pone.0193862  0.318
2018 Roussy M, Bilodeau M, Jouan L, Tibout P, Laramée L, Lemyre E, Cardin S, Sauvageau C, Couture F, Choblet A, Patey N, Gendron P, Duval M, Teira P, Hébert J, ... ... Cellot S, et al. NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy. Genes, Chromosomes & Cancer. PMID 29427526 DOI: 10.1002/Gcc.22532  0.371
2018 Cardin S, Bilodeau M, Laramee L, Jouan L, Roussy M, Humphries RK, Hebert J, Wilhelm BT, Cellot S. Abstract A19: Human models of multilineage leukemia induced by NUP98-KDM5A chimeric fusion oncogene Cancer Research. 78. DOI: 10.1158/1538-7445.Pedca17-A19  0.497
2017 Lagacé K, Barabé F, Hebert J, Cellot S, Wilhelm BT. Identification of novel biomarkers for MLL translocated acute myeloid leukemia. Experimental Hematology. PMID 28911906 DOI: 10.1016/J.Exphem.2017.08.006  0.413
2017 Khater F, Lajoie M, Langlois S, Healy J, Cellot S, Richer C, Beaulieu P, St-Onge P, Saillour V, Minden M, Marzouki M, Krajinovic M, Bittencourt H, Sinnett D. KMT2E-ASNS: a novel relapse-specific fusion gene in early T-cell precursor acute lymphoblastic leukemia. Blood. PMID 28069604 DOI: 10.1182/Blood-2016-10-744219  0.357
2016 Barabé F, Gil L, Celton M, Bergeron A, Lamontagne V, Roques É, Lagacé K, Forest A, Johnson R, Pécheux L, Simard J, Pelloux J, Bellemare-Pelletier A, Gagnon E, Hebert J, ... Cellot S, et al. Modeling human MLL-AF9 translocated acute myeloid leukemia from single donors reveals RET as a potential therapeutic target. Leukemia. PMID 27780967 DOI: 10.1038/Leu.2016.302  0.49
2016 Ceppi F, Duval M, Leclerc JM, Laverdiere C, Delva YL, Cellot S, Teira P, Bittencourt H. Improvement of the Outcome of Relapsed or Refractory Acute Lymphoblastic Leukemia in Children Using a Risk-Based Treatment Strategy. Plos One. 11: e0160310. PMID 27632202 DOI: 10.1371/Journal.Pone.0160310  0.323
2016 Cardin S, Laramee L, MacRae T, Chagraoui J, Sauvageau G, Humphries RK, Hébert J, Wilhelm BT, Cellot S. Modeling of Pediatric Acute Megakaryoblastic Leukemia Using Cord Blood Stem/Progenitor Cells Blood. 128: 1535-1535. DOI: 10.1182/Blood.V128.22.1535.1535  0.711
2015 Bittencourt H, Vachon M, Louis I, Chablis E, Cortier M, Villeneuve E, Teira P, Cellot S, Haddad E, Duval M. Intrabone Infusion of Umbilical Cord Blood Stem Cells to Improve Hematopoietic Recovery after Allogeneic Umbilical Cord Blood Transplantation in Children Blood. 126: 4334-4334. DOI: 10.1182/Blood.V126.23.4334.4334  0.448
2014 Cellot S. RNAi functional screen involving Jumonji family gene candidates identifies KDM5B/JARID1B as a regulator of mouse hematopoietic stem cell fate Experimental Hematology. 42: S4. DOI: 10.1016/J.Exphem.2014.07.012  0.598
2013 Tran TH, Mitchell D, Dix D, Cellot S, Ethier MC, Gillmeister B, Hitzler J, Lewis V, Yanofsky R, Johnston DL, Portwine C, Price V, Zelcer S, Silva M, Michon B, et al. Infections in children with down syndrome and acute myeloid leukemia: a report from the Canadian infections in AML research group. Infectious Agents and Cancer. 8: 47. PMID 24289042 DOI: 10.1186/1750-9378-8-47  0.31
2013 Cellot S, Hope KJ, Chagraoui J, Sauvageau M, Deneault É, MacRae T, Mayotte N, Wilhelm BT, Landry JR, Ting SB, Krosl J, Humphries K, Thompson A, Sauvageau G. RNAi screen identifies Jarid1b as a major regulator of mouse HSC activity. Blood. 122: 1545-55. PMID 23777767 DOI: 10.1182/Blood-2013-04-496281  0.766
2013 Ramsey JM, Kettyle LM, Sharpe DJ, Mulgrew NM, Dickson GJ, Bijl JJ, Austin P, Mayotte N, Cellot S, Lappin TR, Zhang SD, Mills KI, Krosl J, Sauvageau G, Thompson A. Entinostat prevents leukemia maintenance in a collaborating oncogene-dependent model of cytogenetically normal acute myeloid leukemia. Stem Cells (Dayton, Ohio). 31: 1434-45. PMID 23592435 DOI: 10.1002/Stem.1398  0.608
2013 Johnston DL, Lewis V, Yanofsky R, Gillmeister B, Ethier MC, Mitchell D, Cellot S, Dix D, Portwine C, Price V, Silva M, Zelcer S, Michon B, Bowes L, Stobart K, et al. Invasive fungal infections in paediatric acute myeloid leukaemia. Mycoses. 56: 482-7. PMID 23437849 DOI: 10.1111/Myc.12063  0.354
2013 Ceppi F, Duval M, Laverdiere C, Leclerc J, Delvas Y, Cellot S, Teira P, Bittencourt H. Outcome After First Relapse Or Refractory Acute Lymphoblastic Leukemia In Children From 1996 To 2011 – Comparison Of Two Different Treatment Strategies Blood. 122: 3381-3381. DOI: 10.1182/Blood.V122.21.3381.3381  0.34
2013 Tran TH, Yanofsky R, Johnston D, Dix D, Gillmeister B, Ethier M, Portwine C, Price VE, Mitchell D, Cellot S, Lewis VA, Zelcer S, Silva M, Michon B, Bowes L, et al. Second Bacteremia During Antibiotic Treatment In Children With Acute Myeloid Leukemia: A Report From The Canadian Infections In AML Research Group Blood. 122: 1415-1415. DOI: 10.1182/Blood.V122.21.1415.1415  0.337
2012 Dix D, Cellot S, Price V, Gillmeister B, Ethier MC, Johnston DL, Lewis V, Michon B, Mitchell D, Stobart K, Yanofsky R, Portwine C, Silva M, Bowes L, Zelcer S, et al. Association between corticosteroids and infection, sepsis, and infectious death in pediatric acute myeloid leukemia (AML): results from the Canadian infections in AML research group. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 55: 1608-14. PMID 22955431 DOI: 10.1093/Cid/Cis774  0.323
2012 Herault O, Hope KJ, Deneault E, Mayotte N, Chagraoui J, Wilhelm BT, Cellot S, Sauvageau M, Andrade-Navarro MA, Hébert J, Sauvageau G. A role for GPx3 in activity of normal and leukemia stem cells. The Journal of Experimental Medicine. 209: 895-901. PMID 22508837 DOI: 10.1084/Jem.20102386  0.81
2012 Ting SB, Deneault E, Hope K, Cellot S, Chagraoui J, Mayotte N, Dorn JF, Laverdure JP, Harvey M, Hawkins ED, Russell SM, Maddox PS, Iscove NN, Sauvageau G. Asymmetric segregation and self-renewal of hematopoietic stem and progenitor cells with endocytic Ap2a2. Blood. 119: 2510-22. PMID 22174158 DOI: 10.1182/Blood-2011-11-393272  0.84
2011 Cellot S, Hope KJ, Sauvageau M, Chagraoui J, Deneault E, MacRae T, Mayotte N, Sauvageau G. A Functional In Vivo RNAi screen Involving Jumonji C Domain Containing Candidates Unravels Kdm5b As a Negative Modulator of Hematopoietic Stem Cell Self-Renewal Blood. 118: 385-385. DOI: 10.1182/Blood.V118.21.385.385  0.826
2010 Hope KJ, Cellot S, Ting SB, MacRae T, Mayotte N, Iscove NN, Sauvageau G. An RNAi screen identifies Msi2 and Prox1 as having opposite roles in the regulation of hematopoietic stem cell activity. Cell Stem Cell. 7: 101-13. PMID 20621054 DOI: 10.1016/J.Stem.2010.06.007  0.763
2010 Herault O, Hope KJ, Deneault E, Trost M, Mayotte N, Chagraoui J, Wilhelm BT, Cellot S, Sauvageau M, Thibault P, Sauvageau G. Gpx3 Determines Competitiveness of Normal and Leukemic Stem Cells. Blood. 116: 1587-1587. DOI: 10.1182/Blood.V116.21.1587.1587  0.819
2009 Deneault E, Cellot S, Faubert A, Laverdure JP, Fréchette M, Chagraoui J, Mayotte N, Sauvageau M, Ting SB, Sauvageau G. A functional screen to identify novel effectors of hematopoietic stem cell activity. Cell. 137: 369-79. PMID 19379700 DOI: 10.1016/J.Cell.2009.03.026  0.812
2009 Hope KJ, Cellot S, Ting S, Sauvageau G. An RNA Interference Screen Identifies the Cell Fate Determinants Msi2 and Prox1 as Novel Regulators of Hematopoietic Stem Cell Self-Renewal. Blood. 114: 394-394. DOI: 10.1182/Blood.V114.22.394.394  0.795
2009 Cellot S, Hope KJ, Sauvageau M, Sauvageau G. Histone Demethylases as Modulators of Hematopoietic Cell Fate. Blood. 114: 393-393. DOI: 10.1182/Blood.V114.22.393.393  0.838
2008 Hope KJ, Cellot S, Ting S, Sauvageau G. An RNA Interference Screen Reveals Fate Determinants Implicated in Asymmetric Cell Division as Potential Regulators of Hematopoietic Stem Cell Self-Renewal Blood. 112: 2462-2462. DOI: 10.1182/Blood.V112.11.2462.2462  0.78
2007 Cellot S, Krosl J, Chagraoui J, Meloche S, Humphries RK, Sauvageau G. Sustained in vitro trigger of self-renewal divisions in Hoxb4hiPbx1(10) hematopoietic stem cells. Experimental Hematology. 35: 802-16. PMID 17577929 DOI: 10.1016/J.Exphem.2007.02.013  0.76
2007 Cellot S, Sauvageau G. Zfx: at the crossroads of survival and self-renewal. Cell. 129: 239-41. PMID 17448983 DOI: 10.1016/J.Cell.2007.04.002  0.724
2006 Cellot S, Sauvageau G. In vitro stem cell expansion: stepping closer towards self-renewal. Gene Therapy. 13: 1617-8. PMID 16738689 DOI: 10.1038/sj.gt.3302804  0.677
2005 Cellot S, Sauvageau G. Gfi-1: another piece in the HSC puzzle. Trends in Immunology. 26: 68-71. PMID 15668120 DOI: 10.1016/J.It.2004.12.005  0.725
2005 Cellot S, Krosl J, Humphries K, Sauvageau G. Deterministic Trigger of Self-Renewal in Expanded HSCs Expressing Hoxb4 + Antisense Pbx1. Blood. 106: 800-800. DOI: 10.1182/Blood.V106.11.800.800  0.834
2004 Cellot S, Krosl J, Humphries K, Sauvageau G. Revealing the Interplay of Extrinsic Versus Intrinsic Regulators of Self-Renewal in Hoxb4-Transduced HSCs. Blood. 104: 367-367. DOI: 10.1182/Blood.V104.11.367.367  0.824
Show low-probability matches.